VanEck Pharmaceutical ETF
137 hedge funds and large institutions have $416M invested in VanEck Pharmaceutical ETF in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
9% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11.48% less ownership
Funds ownership: 88.69% → 77.21% (-11%)
Holders
137
Holding in Top 10
1
Calls
$1.63M
Puts
$499K
Top Buyers
| 1 | +$6.31M | |
| 2 | +$3.71M | |
| 3 | +$3.39M | |
| 4 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
+$3.21M |
| 5 |
Jane Street
New York
|
+$3.16M |
Top Sellers
| 1 | -$19.7M | |
| 2 | -$9.07M | |
| 3 | -$7.77M | |
| 4 |
Morgan Stanley
New York
|
-$6.64M |
| 5 |
VAS
Valicenti Advisory Services
Elmira,
New York
|
-$5.14M |